Diagnostic Accuracy Study of a Novel Blood-Based Assay for Identification of Tuberculosis in People Living with HIV.


Journal

Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564

Informations de publication

Date de publication:
18 02 2021
Historique:
received: 03 07 2020
accepted: 02 12 2020
pubmed: 11 12 2020
medline: 9 7 2021
entrez: 10 12 2020
Statut: epublish

Résumé

A nonsputum triage test to rule out tuberculosis (TB) disease is a WHO high-priority diagnostic, and a combinatory score based on a 3-gene host signature has shown promise in discriminating TB from other illnesses. We evaluated the accuracy of an early-prototype cartridge assay ("Xpert MTB Host Response" or Xpert-MTB-HR-Prototype) of this 3-gene signature on biobanked blood samples from people living with HIV (PLHIV) against a comprehensive microbiological reference standard (CMRS) and against Xpert MTB/RIF on the first sputum sample alone. We depict results based on performance targets set by the WHO in comparison with a laboratory-based C-reactive protein (CRP) assay. Of 201 patients included, 67 were culture positive for

Identifiants

pubmed: 33298607
pii: JCM.01643-20
doi: 10.1128/JCM.01643-20
pmc: PMC8106701
pii:
doi:

Substances chimiques

Rifampin VJT6J7R4TR

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI125197
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI057229
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI109662
Pays : United States

Informations de copyright

Copyright © 2021 Södersten et al.

Références

JAMA Netw Open. 2018 Oct 5;1(6):e183779
pubmed: 30646264
PLoS Med. 2019 Apr 23;16(4):e1002786
pubmed: 31013272
BMC Med. 2015 Aug 14;13:192
pubmed: 26275908
J Clin Invest. 2003 Jun;111(12):1805-12
pubmed: 12813013
AIDS. 2014 Jul 31;28(12):1846-8
pubmed: 25006829
Lancet Respir Med. 2016 Mar;4(3):213-24
pubmed: 26907218
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
BMJ. 2015 Oct 28;351:h5527
pubmed: 26511519
Eur Respir J. 2013 Aug;42(2):544-7
pubmed: 23904551
J Infect. 2017 Dec;75(6):499-510
pubmed: 28941629
Lancet Infect Dis. 2017 Dec;17(12):1285-1292
pubmed: 28847636
Lancet Infect Dis. 2018 Jan;18(1):76-84
pubmed: 29198911

Auteurs

Erik Södersten (E)

Cepheid AB, Solna, Sweden.

Stefano Ongarello (S)

FIND, Geneva, Switzerland.

Anna Mantsoki (A)

FIND, Geneva, Switzerland.

Romain Wyss (R)

FIND, Geneva, Switzerland.

David H Persing (DH)

Cepheid, Sunnyvale, California, USA.

Sara Banderby (S)

Cepheid AB, Solna, Sweden.

Linda Strömqvist Meuzelaar (L)

Cepheid AB, Solna, Sweden.

Jacqueline Prieto (J)

Cepheid AB, Solna, Sweden.

Devasena Gnanashanmugam (D)

Cepheid, Sunnyvale, California, USA.

Purvesh Khatri (P)

Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, California, USA.
Department of Medicine, Division of Biomedical Informatics Research, Stanford University School of Medicine, Stanford, California, USA.

Samuel G Schumacher (SG)

FIND, Geneva, Switzerland Samuel.Schumacher@finddx.org.

Claudia M Denkinger (CM)

FIND, Geneva, Switzerland.
Division of Tropical Medicine, Center for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH